Showing posts with label National Cancer Institute. Show all posts
Showing posts with label National Cancer Institute. Show all posts

Wednesday, May 21, 2014

Why Give Wednesday

At the UAB Comprehensive Cancer Center, our vision is to eliminate cancer as a major public health problem. If that isn’t reason enough to get you inspired to donate, here’s some motivation:

-Give in honor or memory of a loved one. We find out the impact of this disease when it affects the ones we care about. Financially supporting cancer research is a great way to honor a loved one.
-The UAB Comprehensive Cancer Center has an incredible faculty of 350 physicians and researchers dedicated to being the forefront of improving prevention, diagnosis, and treatment. Your donations help ensure the continuation of their cutting-edge research.
-Every dollar stays here in Birmingham, is tax-deductible, and may be designated for the cancer or research area of your choice, or it can be directed to the center’s Fund for Excellence where it will be used for high-priority needs. 
- One of the nation’s leading cancer research and treatment centers, the UAB Comprehensive Cancer Center is the only NCI-designated comprehensive cancer center located in a six-state area that includes Alabama, Mississippi, Louisiana, Arkansas, South Carolina, and Georgia.
Lastly, by giving to the UAB Comprehensive Cancer Center you are supporting a greater philanthropic campaign, which is The Campaign for UAB.  The campaign consists of a $1billion goal and maintains the theme of “Give Something, Change Everything.” The hopeful end result is that UAB be one of the most dynamic and productive universities of the 21st century and attain our vision to be an internationally renowned research university — a first choice for education and health care.

For more information about making a gift toward providing support for innovative programs within the UAB Comprehensive Cancer Center, visit www.uab.edu/cancer.

Friday, July 13, 2012

SPORE grants set UAB apart

The UAB Comprehensive Cancer Center is one of few institutions to have been awarded three or more SPORE (Specialized Program of Research Excellence) grants from the National Cancer Institute. Currently the center holds SPORES in pancreatic and breast cancer and is partnered with John Hopkins University on a cervical cancer SPORE. Additionally, the Cancer Center was the only institution nationwide to receive a SPORE grant in pancreatic cancer in 2010. Why is this grant such a big deal?

It supports projects that will lead to the early detection, prevention, diagnosis and treatment of human cancers. Each SPORE is focused on a specific organ site, such as breast or pancreatic cancer. "SPOREs are designed to enable the rapid and efficient movement of basic scientific findings into clinical settings, as well as to determine the biological basis for observations made in individuals with cancer or in populations at risk for cancer," according to the National Cancer Institute.

Principal investigator Donald J. Buchsbaum, Ph.D., director of radiation biology at the University of Alabama at Birmingham, leads the SPORE program in pancreatic cancer. Support from the NCI was granted because of the Cancer Center's expertise in tumor biology, virology/gene therapy, immunobiology and targeted immunotherapy. Current research projects stem from previously established efforts that showed the most promise.

Kirby I. Bland, M.D., chair of the department of surgery at the University of Alabama at Birmingham, is the principal investigator of the SPORE program in breast cancer. In order to best accomplish the goal of prevention, detection, prognosis and therapy development, this project assembled many basic and clinical scientists, including molecular/cell biologists, pathologists, medical/surgical oncologists, experts in the development of new technologies, and biostatisticians.

There are currently 62 grants across 23 states in the country. UAB claims Alabama's only SPORE grants. Just another example of what sets the UAB Comprehensive Cancer Center apart.

-Ed Partridge, M.D.